700 patients110,866 observations180 daysLIVE

Patient P-02430

Synthetic patientMETA-24 · Day 170 · 25–34 · M · baseline S07Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
16%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S07
  2. Day 32 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 32.

Primary contributors, last 14 days
  • GI instability-25
  • Nutritional resilience+7
  • Treatment adherence+6
  • Inflammatory activity-4

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    69 min
    stable · +2.1 vs previous 14 d
    Sleep duration
    Wearable
    8.3 h
    improving · +0.3 vs previous 14 d
    Energy level
    Daily log
    6.6/10
    improving · +0.6 vs previous 14 d
    Steps
    Wearable
    7,776
    stable · +256 vs previous 14 d
    GI burden
    Companion
    15.6/100
    improving · -7.7 vs previous 14 d
    Adherence
    Companion
    92.7 %
    stable · +0.4 vs previous 14 d
    Sleep quality
    Wearable
    72.9/100
    improving · +6.2 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    119 mg/dL
    stable · -2.0 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 76 from the failing basin, 16 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +8.7
    • Butyrate producers intact
      hidden · steering +7.5
    • Dietary fat load (supports)
      perturbation · steering +3.7
    • Histamine load (supports)
      perturbation · steering +3.3
    • Protein
      supporter · GI -4.3 next day
    • Dietary fat load
      supporter · GI -2.4 next day
    Main detractors to watch
    • Bacteroides fragilis elevated
      hidden · steering -7.4
    • Poor-sleep week
      perturbation · steering -3
    • Dietary drift
      perturbation · steering -2.6
    • Alcohol on dosing days
      perturbation · steering -1.8
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -4.3supporter · 95%
    • Dietary fat load
      -2.4supporter · 65%
    • Histamine load
      -2.2supporter · 76%
    • Ultra-processed food
      +0.8no signal · 25%
    • Caffeine
      -0.7no signal · 18%
    • Insoluble fibre
      -0.6no signal · 18%
    • Simple carbohydrates
      +0.2no signal · 15%
    • Alcohol
      +0.1no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity 30
      • MicrobiomeAkkermansia low → thinner mucus layer
    • Butyrate / short-chain fatty acid production 25
      • MicrobiomeF. prausnitzii depleted
    • Inflammatory signalling 20
      • MicrobiomeBacteroides fragilis expansion
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Normal metabolizer
      Expected exposure
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 3.7 · butyrate capacity 63/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    44 ms
    Sleep
    7.9 h
    Steps
    6,684
    Resting HR
    70 bpm
    Daily log: GI score 16, nutritional resilience 61, adherence 93.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0248343%S06BR-03no change64
    P-0226734%S09BR-03no change45
    P-0228034%S07BR-03no change50
    P-0228232%S01BR-03no change88
    P-0235436%S01CR-01improved78
    P-0246245%S12DT-01improved65
    P-0249145%S09DT-01no change65
    P-0251843%S17DT-01improved68
    P-0227436%S15DT-01improved50
    P-0233936%S03DT-01improved50
    P-0223535%S14DT-01improved50
    P-0245535%S09DT-01improved50